Authors:
Marschner, IC
Colquhoun, D
Simes, RJ
Glasziou, P
Harris, P
Singh, BB
Friedlander, D
White, H
Thompson, P
Tonkin, A
Citation: Ic. Marschner et al., Long-term risk stratification for survivors of acute coronary syndromes - Results from the long-term intervention with pravastatin in ischemic disease (LIPID) study, J AM COL C, 38(1), 2001, pp. 56-63
Authors:
Reid, IR
Hague, W
Emberson, J
Baker, J
Tonkin, A
Hunt, D
MacMahon, S
Sharpe, N
Citation: Ir. Reid et al., Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial, LANCET, 357(9255), 2001, pp. 509-512
Authors:
Hunt, D
Young, P
Simes, J
Hague, W
Mann, S
Owensby, D
Lane, G
Tonkin, A
Citation: D. Hunt et al., Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial, ANN INT MED, 134(10), 2001, pp. 931-940
Authors:
Taverner, D
Bickford, L
Shakib, S
Tonkin, A
Citation: D. Taverner et al., Evaluation of the dose-response relationship for intra-nasal oxymetazolinehydrochloride in normal adults, EUR J CL PH, 55(7), 1999, pp. 509-513
Citation: S. Shah et al., Implementation of nationally developed guidelines in cardiology: a survey of NSW cardiologists and cardiothoracic surgeons, AUST NZ J M, 29(5), 1999, pp. 678-683